Neuburgh Advisers’s ResMed RMD Stock Holding History

Neuburgh Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$859K	Sell	6,358 -1,156	-15%	-$151K	0.03%	348
2019 Q2	$917K	Sell	7,514 -1,428	-16%	-$158K	0.03%	329
2019 Q1	$930K	Buy	8,942 +2,482	+38%	+$256K	0.03%	310
2018 Q4	$736K	Sell	6,460 -1,088	-14%	-$117K	0.03%	319
2018 Q3	$871K	Sell	7,548 -170	-2%	-$18.6K	0.03%	326
2018 Q2	$799K	Buy	7,718 +238	+3%	+$24.1K	0.03%	323
2018 Q1	$737K	Sell	7,480 -544	-7%	-$51.4K	0.03%	321
2017 Q4	$680K	Buy	8,024 +612	+8%	+$50.6K	0.02%	352
2017 Q3	$571K	Sell	7,412 -10,200	-58%	-$780K	0.02%	369
2017 Q2	$1.37M	Buy	17,612 +5,440	+45%	+$389K	0.05%	228
2017 Q1	$876K	Sell	12,172 -3,774	-24%	-$261K	0.03%	288
2016 Q4	$989K	Buy	+15,946	New	+$977K	0.04%	241

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuburgh Advisers's RMD Position: Q3 2019 in Review

Neuburgh Advisers reduced its ResMed (RMD) stake by 15% in Q3 2019, selling an estimated $151K and leaving 6,358 shares worth $859K. The position accounts for 0.03% of the portfolio, ranked #348.

Neuburgh Advisers first reported a position in RMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.37M in Q2 2017. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

Neuburgh Advisers held 6,358 shares of ResMed worth $859K as of Q3 2019.
Neuburgh Advisers sold 1,156 ResMed shares in Q3 2019, an estimated $151K.
ResMed made up 0.03% of Neuburgh Advisers's portfolio in Q3 2019, its #348 holding.
Neuburgh Advisers first reported a position in ResMed in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's ResMed position peaked at $1.37M in Q2 2017.
527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.